Overview
Maria Laplana practices practicing medicine in Barcelona, Spain.
Her clinical expertise encompasses Triple-Negative Breast Cancer, Breast Cancer, and Mastectomy.
She is actively involved in clinical research, co-authoring 14 peer reviewed articles and participating in 1 clinical trial.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Frequently Asked Questions about Maria Laplana
Is Maria Laplana a top-rated expert for Triple-Negative Breast Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Maria Laplana is classified as an Experienced expert for Triple-Negative Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Maria Laplana participate in research or clinical trials?
Yes. Maria Laplana has published 14 articles and abstracts on conditions like Triple-Negative Breast Cancer. You can view a list of Maria Laplana's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Breast CancerMs. Laplana isExperienced. Learn about Breast Cancer.
- MastectomyMs. Laplana isExperienced. Learn about Mastectomy.
- Triple-Negative Breast CancerMs. Laplana isExperienced. Learn about Triple-Negative Breast Cancer.